Newsletter Archive

31. 03.17.25 -- AI In A Time Of Uncertainty: Key Strategies To Enable Flexibility 3/17/2025
    03/17/25 Life Science Leader Newsletter
32. 03.14.25 -- A CEO With A General Counsel's Perspective 3/14/2025
    03/14/25 Life Science Leader Newsletter
33. 03.13.25 -- Optimize Your High Concentration Biologic Production Process 3/13/2025

    03/13/25 Life Science Leader Newsletter

34. 03.12.25 -- Interchangeability In Leadership: A Career Built On Versatility 3/12/2025
    03/12/25 Life Science Leader Newsletter
35. 03.10.25 -- An Updated View of The Federal Segment: DHA Formulary Management 3/10/2025
    03/10/25 Life Science Leader Newsletter
36. 03.10.25 -- Patient Engagement Through Community Research 3/10/2025

    03/10/25 Life Science Leader Newsletter

37. 03.08.25 -- Life Science Leader Best Of February 3/8/2025
    03/08/25
38. 03.07.25 -- An Updated View of The Federal Segment: DHA Formulary Management 3/7/2025
    03/07/25 Life Science Leader Newsletter
39. 03.07.25 -- Gene Therapies for Cardiac Care, ATMP Patient Access, and Biotech Partnership Strategies. Listen now! 3/7/2025
    03/07/25 Life Science Leader Newsletter
40. 03.05.25 -- FCPA Enforcement Paused At DOJ, But Biopharma Shouldn't Pause Compliance 3/5/2025
    03/05/25 Life Science Leader Newsletter